In this study, we mainly investigated the novel marker IQGAP3 at serum and tumor tissue levels compared with the markers B7-H4 and COX-2 in patients with CRC and in healthy individuals, aiming to evaluate the diagnostic and prognostic value of IQGAP3 for CRC. Here, VTCN1 is linked to neoplasm.